title: Hematopoietic specification from human pluripotent stem cells: current advances and challenges toward de novo generation of hematopoietic stem cells.
abstract: Significant advances in cellular reprogramming technologies and hematopoietic differentiation from human pluripotent stem cells (hPSCs) have already enabled the routine production of multiple lineages of blood cells in vitro and opened novel opportunities to study hematopoietic development, model genetic blood diseases, and manufacture immunologically matched cells for transfusion and cancer immunotherapy. However, the generation of hematopoietic cells with robust and sustained multilineage engraftment has not been achieved. Here, we highlight the recent advances in understanding the molecular and cellular pathways leading to blood development from hPSCs and discuss potential approaches that can be taken to facilitate the development of technologies for de novo production of hematopoietic stem cells.
authors.affiliation: Department of Pathology and Laboratory Medicine, and.
authors.forename: Igor I
authors.initials: II
authors.lastname: Slukvin
mesh_terms: D000818:Animals; D002454:Cell Differentiation; D004195:Disease Models, Animal; D030342:Genetic Diseases, Inborn / Q000378:metabolism* / Q000473:pathology / Q000628:therapy; D006402:Hematologic Diseases / Q000378:metabolism* / Q000473:pathology / Q000628:therapy; D006412:Hematopoietic Stem Cells / Q000378:metabolism*; D006801:Humans; D009369:Neoplasms / Q000378:metabolism* / Q000473:pathology / Q000628:therapy; D039904:Pluripotent Stem Cells / Q000378:metabolism*; D033581:Stem Cell Transplantation / Q000379:methods